Treatment of Parkinsonian syndrome with dexetimide.

Abstract

In an open study, 60 Parkinson patients with varying aetiology were submitted to a treatment with the long-acting antiparkinsonian drug dexetimide and L-Dopa. Rigor, tremor and akinesia were favourably influenced. An advantage over other antiparkinsonian agents is its long duration of action and the possibility of a simple dosage. Further investigations concerning its long-term effect and elucidation of its interactions with different drugs commonly administered in parkinsonian disorders seem desirable.

• Authors: J Deze, G W Völler
• Journal: Acta psychiatrica Belgica (Acta Psychiatr Belg) 1979 Nov-Dec Vol. 79 Issue 6 Pg. 704-11 ISSN: 0300-8967 [Print] Belgium
• PMID: 554448 (Publication Type: Journal Article)

Chemical References

• Piperidines
• Dexetimide
• Levodopa

Topics

• Adult
• Aged
• Chemical Phenomena
• Chemistry
• Dexetimide (administration & dosage, adverse effects)
• Drug Therapy, Combination
• Female
• Humans
• Levodopa (administration & dosage)
• Male
• Middle Aged
• Parkinson Disease (drug therapy)
• Piperidines (administration & dosage)